Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Partnership researching genetics and treatments of long COVID

May 11, 2022 Research and Development

PrecisionLife Limited have announced a partnership with Sano Genetics, a genetic research platform enabling patients to participate in ethical research …
News

Ardena confirms spray drying upgrade and other capabilities at Spanish site

May 11, 2022 Research and Development

 
News

NIH launches clinical trial of vaccine for Epstein-Barr virus

May 9, 2022 Research and Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an …
News

BLINCYTO approved in China for leukaemia treatment

May 4, 2022 Research and Development

The China National Medical Products Administration (NMPA) has granted conditional approval of BLINCYTO (blinatumomab), as an injection for the treatment …
News

Amphista Therapeutics and Bristol Myers Squibb partner for development of protein degradation therapeutics

May 4, 2022 Research and Development

Amphista and Bristol-Myers Squibb have announced a strategic collaboration and license agreement.Under the terms of the collaboration, BMS and Amphista …
News

Smartphone app could screen for Alzheimer’s disease

May 4, 2022 Research and Development

Researchers at the University of California San Diego have developed a smartphone app with the potential to screen for Alzheimer’s …
News

WHO announce upcoming updates on treatment of drug-resistant tuberculosis

May 4, 2022 Research and Development

A rapid communication released by WHO Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of …
News

Quell Therapeutics and Cellistic collaborate to develop T-regulatory cell therapy platform

April 27, 2022 Research and Development

Quell Therapeutics and Cellistic have entered into a strategic collaboration for the co-development of an iPSC-derived Treg cell therapy platform. …
News

Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis

April 27, 2022 Research and Development

Orexo has announced that their partner, Gesynta Pharma has been granted Orphan Drug Designation by the FDA, for OX-MPI (GS248), …
News

Enhertu granted FDA Breakthrough Therapy Designation

April 27, 2022 Research and Development

AstraZeneca’s Enhertu® (fam-trastuzumab deruxtecan-nxki) has been granted breakthrough therapy designation in the US for adult patients with HER2-low metastatic breast …
News

Takeda Nuvaxovid COVID-19 vaccine approved in Japan

April 20, 2022 Research and Development

Takeda’s Nuvaxovid Intramuscular Injection (Nuvaxovid) has been approved by the Japan Mnistry of Health, Labour and Welfare (MHLW). This is …
News

Care to Collaborate: Cydar Medical announces partnership with Medtronic

April 20, 2022 Research and Development

Cydar Medical has announced a strategic collaboration with leading healthcare technology company Medtronic. Under the pilot arrangement, Cydar’s EV Maps …
News

Study initiated for first miniaturised robotic-assisted surgery platform

April 20, 2022 Research and Development

Virtual Incision Corporation has announced the FDA approval of an Investigational Device Exemption (IDE) supplement to complete the final stage …
News

NHS Health Chief calls for return of facemasks and social distancing

April 20, 2022 Research and Development

Chris Hopson, Chief Executive of NHS Providers, which represents trusts has urged ministers to discuss “sensible precautions” for the public, …
News

VistaGen and AffaMed complete regulatory submissions for Phase III SAD trial

April 13, 2022 Research and Development

VistaGen and AffaMed have announced the completion of key regulatory preparations to initiate PALISADE global, a Phase III clinical trial …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026